Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
AspenBio Pharma provides updates on appendicitis test, other products
December 24th, 2006
AspenBio Pharma, Inc. (APNB) highlighted the advancement of several key, high-value products, including: 1) Positive developments continued with AspenBio Pharma's unique blood-based human appendicitis test. Results from initial clinical testing conducted at multiple hospitals continued during the quarter and show the test achieving definitive indications of a high level of correlation with acute appendicitis in the age group most likely to experience the condition, and thereby suggesting tremendous diagnostic value. The company believes its test would represent significant advantages in the state of the art techniques as currently used by emergency room doctors to...
Source: Medical Devices & Surgical Technology Week (2006-12-24)
|
